Company Monitoring Page for JNJ

latest headlines for company on cafepharma

Biosimilars Council Sides with Pfizer in Antitrust Dispute with J&J
JD Supra
Tue, 02/6/18 - 08:40 pm
Tags:
biosimilars, Pfizer, JNJ, antitrust, Remicade, Inflectra
How Johnson & Johnson Medical Devices Companies are working with healthcare customers to achieve the goal of value-based care
Medical Devices and Diagnostics Industry
Tue, 02/6/18 - 08:39 pm
Tags:
JNJ, devices, value-based care
Johnson & Johnson falls on report that lawsuits could expose potentially damaging documents
CNBC
Tue, 02/6/18 - 11:47 am
Tags:
JNJ, ovarian cancer
Strong data lift profile of J&J's cancer drug apalutamide
Biopharma Dive
Tue, 02/6/18 - 11:45 am
Tags:
JNJ, apalutamide, prostate cancer
Biopharma in charts: Key takeaways from Q4 earnings
Biopharma Dive
Mon, 02/5/18 - 12:35 pm
Tags:
earnings, Merck, JNJ, AbbVie, Roche, Celgene, Eli Lilly
[video]Johnson & Johnson's Earnings Were Solid, but Questions Remain
Motley Fool
Thu, 02/1/18 - 09:30 pm
Tags:
JNJ, earnings
Johnson & Johnson drops out of the race for Pfizer consumer unit, paving the way for GSK, Reckitt
Fierce Pharma
Thu, 01/25/18 - 05:29 pm
Tags:
JNJ, Pfizer, consumer health, M&A, GSK, Reckitt Benckiser
Why J&J Expects 2018 to be a Growth Year
Medical Devices and Diagnostics Industry
Wed, 01/24/18 - 09:12 am
Tags:
JNJ, devices, Alex Gorsky
J&J’s move to cut Remicade price cost some big bucks, but guarded against Pfizer’s copycat
Endpoints
Tue, 01/23/18 - 09:00 pm
Tags:
JNJ, Remicade, drug pricing, Pfizer, biosimilars
Johnson & Johnson logs Q4 beat, misses with 2017 numbers
Mass Device
Tue, 01/23/18 - 08:44 am
Tags:
JNJ, earnings, devices
Consortium of Chinese companies tries to acquire J&J’s LifeScan and Calibra Medical ($3-4bn)
GoinPharma
Sun, 01/21/18 - 10:43 am
Tags:
China, JNJ, LifeScan, Calibra, M&A
Patent setback could sting J&J prostate cancer franchise
Biopharma Dive
Fri, 01/19/18 - 11:11 am
Tags:
patents, JNJ, prostate cancer, Zytiga, Xtandi, Astellas
With Pfizer in hot pursuit, J&J loses a critical patent fight as it scrambles for a new prostate cancer drug OK
Endpoints
Thu, 01/18/18 - 10:00 am
Tags:
Pfizer, JNJ, patents, Zytiga, Xtandi, prostate cancer, apalutamide
J&J (JNJ) to Set Pharma Q4 Earnings in Motion: What's Up?
Yahoo/Zacks.com
Thu, 01/18/18 - 09:59 am
Tags:
JNJ, earnings
Novartis goes 2-0 against J&J in psoriasis
Biopharma Dive
Wed, 01/17/18 - 11:36 am
Tags:
Novartis, JNJ, psoriasis, Cosentyx, Stelara
Can a hip replacement kill you: lack of regulation in the med device industry
NY Times, NY
Mon, 01/15/18 - 11:00 am
Tags:
FDA, devices, regulation, hip implants, JNJ, Medtronic
J&J chief’s pharma-tech vision is pretty, but it’s certainly not reality: experts
Fierce Pharma
Thu, 01/11/18 - 09:50 am
Tags:
JNJ, Pharma CEOs, Alex Gorsky, JPMHC 2018, technology, Silicon Valley
Bayer, J&J win reversal of $28 million verdict in Xarelto lawsuit
Reuters
Wed, 01/10/18 - 06:56 pm
Tags:
Bayer, JNJ, bloodthinners, Xarelto
J&J chief Gorksy bullish on tax reform, plans $16B in repatriated overseas cash
Mass Device
Wed, 01/10/18 - 11:38 am
Tags:
tax reform, JNJ, Pharma CEOs, Alex Gorsky, M&A
Johnson & Johnson Wants to Create a Crisis -- and That's Great for Investors
Motley Fool
Tue, 01/9/18 - 10:14 am
Tags:
JNJ, JPMHC 2018, Alex Gorsky

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.